Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 7634267

[Microcirculation and remodelling].

P G Camici·R Lorenzoni
View original source ↗Export metadata ↓

Abstract

Acute myocardial infarction can produce alterations in the topography of the left ventricle both in the infarcted and remote areas. These changes as a whole, have been termed ventricular remodelling. Attention has been focused on myocyte alterations due to the remodelling process, but the myocardial wall also contains fibroblasts, which produce collagen and elastin fibers, and endothelial and smooth muscle cells which are the main constituents of the vascular wall. In left ventricular hypertrophy, a form of myocardial remodelling, structural changes of myocytes, cardiac interstitium as well as the coronary microcirculation have been found (vascular remodelling). In vivo, the function of coronary microcirculation can be evaluated by measuring myocardial blood flow and coronary reserve. In fact the study of coronary reserve in patients with left ventricular hypertrophy disclosed microcirculatory dysfunction which probably represents the functional counterpart of the structural changes already described. Positron emission tomography (PET) can noninvasively quantitate myocardial blood flow and coronary reserve in humans. Recently studies with PET disclosed microcirculatory alterations also in patients with coronary artery disease (CAD) in the absence of gross myocardial hypertrophy. In particular, after myocardial infarction, coronary vasodilator capacity has been shown to be impaired not only in the infarcted areas but also in the remote ones subtended by angiographically normal vessels. A blunted coronary reserve has been identified with PET also in remote regions from ischemia in patients with stable angina and single vessel CAD.

Explore related subjects

Angina PectorisCoronary VesselsHumansHypertrophy, Left VentricularMicrocirculationMyocardial InfarctionEnglish AbstractJournal ArticleReview

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P G Camici, R Lorenzoni. 1994. [Microcirculation and remodelling].. https://pubmed.ncbi.nlm.nih.gov/7634267/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

Comparison of activation process of platelets and neutrophils after coronary stent implantation versus balloon angioplasty for stable angina pectoris.

The pathophysiologic features of stent-induced cellular responses of platelets and leukocytes have not been established. This study was designed to clinically investigate the activation of platelets and neutrophils after coronary stenting and to identify its effects on the long-term results of coronary stents. Forty-eight consecutive patients with left anterior descending coronary artery disease indicating coronary intervention were randomly assigned to either a balloon angioplasty group or a coronary stent group. Flow cytometric analysis demonstrated that the transcardiac gradient (the value of coronary sinus blood minus the value of peripheral blood) of platelet surface expression of CD62P (p < 0.001) and CD63 (p < 0.01) increased immediately after coronary stenting, but increased less significantly immediately after balloon angioplasty (CD62P, p < 0.01; CD63, p < 0.05). These increases were persistently observed after coronary stenting but transiently after balloon angioplasty alone during a 48-hour observation period after the procedures. The gradient for neutrophil surface expression of CD11b increased, and that of CD62 L decreased 48 hours after coronary stenting (CD11b, p < 0.001; CD62 L, p < 0.05), but these changes showed less significance 48 hours after balloon angioplasty alone (CD11b, p < 0.05; CD62 L, p = NS). The gradients 48 hours after the procedures for both CD62P (r = 0.39, p < 0.05) and CD11b (r = 0.44, p < 0.01) were independently correlated with the late loss in the stent group, whereas the correlation was seen only for CD11b (r = 0.38, p < 0.05) in the balloon angioplasty group. Both platelet and neutrophil activation was greater after coronary stenting than after balloon angioplasty. Cellular interactions between platelets and neutrophils may be related to the progression of neointimal proliferation leading to restenosis after coronary stent implantation.

Angina Pectoris↗
PubMed2000

[Ischemic preconditioning. Does this animal experiment phenomenon have clinical relevance?].

BACKGROUND: Infarct size following coronary artery occlusion can be markedly reduced by brief preceding periods of ischemia in several animal models. This phenomenon is called "ischemic preconditioning" and is one of the most powerful mechanisms of cardioprotection known to date. PRECONDITIONING IN HUMANS: There is increasing evidence that preconditioning effects exist in humans as well. The occurrence of angina prior to myocardial infarction might result in reduction of infarct size depending on the time pattern of preinfarct-angina. Similarly, "walking-through-angina", i.e., the relief of exercise-induced anginal symptoms with continuing exercise, is attributed to cardioprotection by ischemic preconditioning. During coronary angioplasty, a lesser shift of ST segments in the intracardial ECG and reduced anginal symptoms are registered during a second balloon inflation in comparison with the first balloon inflation. These findings might represent a "preconditioning-like" effect of the first balloon inflation. THERAPEUTICAL IMPLICATIONS: With respect to the mechanisms of ischemic preconditioning identified in animal models some pharmacological agents that exhibit a "preconditioning-like" cardioprotective effect have been intensively investigated. In clinical studies it was demonstrated that application of adenosine, adenosine-receptor-agonists, and dipyridamole--a nucleoside-transport inhibitor--prior to coronary angioplasty results in reduced ischemia during the subsequent balloon inflation. In a randomized trial the treatment with nicorandil, an activator of the ATP-sensitive potassium channel (K-ATP channel) in patients with unstable angina resulted in a marked reduction of myocardial ischemia which also can be attributed to a "preconditioning-like" effect. Therapeutical applications of ischemic preconditioning have been developed in different clinical settings: brief periods of ischemia and "pharmacologic preconditioning" prior to coronary angioplasty, prior to cardiac surgery, and for protection of donor heart for cardiac transplantation were performed to induce cardioprotection. Moreover, possible "anti-preconditioning effects" of several drugs have to be carefully considered for the treatment of patients with coronary artery disease. In particular, patients treated for acute myocardial infarction by coronary angioplasty with concomitant sulfonylurea drug therapy using glibenclamide demonstrated an increased early mortality. CONCLUSION: To raise the step from "laboratory-based protection" to "evidence-based medicine" further research should focus on clinical studies transferring the results from animal models to the clinical setting.

Angina Pectoris↗